Drug Delivery Solutions Market
Drug Delivery Solutions Market By Product Type (Bottles, Vials & Ampoules, Blisters, Bags & Pouches, Prefilled Syringes & Cartridges, Sachets, Trays, Tubes, Caps & Closures, Container, Jars), Material (Plastics, Glass, Metals, Paper) & Region - Forecast 2021 - 2031
Market Insights on Drug Delivery Solutions covering sales outlook, demand forecast & up-to-date key trends
Drug Delivery Solutions Market Outlook – 2021-2031
[275 pages Report] The global drug delivery solutions market size was valued at US$ 94.3 Bn in 2021 and is projected to reach US$ 181.9 Bn by the end of 2031, exhibiting growth at 6.8% CAGR between 2021 and 2031.
|
Drug Delivery Solutions Market Size 2021 |
US$ 94.3 Bn |
|
Drug Delivery Solutions Market Size 2031 |
US$ 181.9 Bn |
|
Value CAGR (2021-2031) |
6.8% |
|
Collective Value Share: Top 3 Countries (2021E) |
33% |
Regionally, South Asia is expected to dominate the drug delivery solutions market. In 2021, the drug delivery solutions market in India grew by 10.6% year-over-year (y-o-y), amid growing demand for drug delivery solution, following the outbreak of COVID-19.
Across South Asia, total sales of drug delivery solutions are estimated to reach US$ 33.2 Bn in 2031.
2015-2020 Drug Delivery Solutions Market Outlook Compared to 2021-2031 Forecast
Future Market Insights has predicted the global drug delivery solutions market to rise at 6.8% CAGR from 2021 to 2031 in comparison to the 5.1% CAGR registered during 2015 to 2020. As per the study, the drug delivery solutions market is expected to hold almost about 5.8% of the healthcare industry.
Rising popularity of biological drug medications is expected to create new tailwinds for the demand in the market. These new medications are unique in relation to small molecule formulations, as a result, demand for new formats and materials is surging.
In terms of material, the glass vial packaging format is gaining immense popularity, propelling the demand in the market. Some novel biologics have properties that delaminate glass, prompting undesirable glass chipping in formulations.
Hence, key manufacturers are developing vials that are resistant to harsh temperature and improved in heating procedure so that chipping can be alleviated. Thus, new biological drug formulations are driving the demand for new packaging formats.
Regionally, Europe pharmaceutical packaging market is witnessing a growing trend of advanced design and technological features being incorporated in packaging products.
Conventional and widely used pharmaceutical packaging solutions such as blister packs and pharmaceutical bottles are incorporated with digital technology that features advanced functionality for end-user and patients.
Let us know your requirement to get
100% FREE customization
Preference for Disposable Packaging Fuelling Demand for Drug Delivery Solutions
Conventional pharmaceutical packaging solutions include wraps and cotton among others. Advent of thermoformable materials enabled the usage of new packaging solutions such as thermoformed trays and blister packaging.
Consequently, growing demand for good lidding materials encouraged the manufacturers of pharmaceutical packaging solutions to come up with new packaging solutions with improved film laminations, increasing the adoption of thermoplastic polymers.
As the quality of healthcare continues to improve across the globe, it is anticipated that the global pharmaceutical packaging market will benefit from the surging demand for newer drug delivery solutions.
How is Demand for Flexible Packaging Solutions Affecting Drug Delivery Solutions Companies?
Rigid packaging products, traditionally preferred in the pharmaceutical industry, are rapidly being replaced by flexible packaging products made of plastics. Growing preference for flexible packaging and particularly for high-performance applications, is expected to generate new opportunities for packaging barrier films.
Steered by its lightweight, flexible, and durable properties flexible plastics, are increasingly replacing rigid packaging made of rigid plastics and other non-plastic materials (including glass and metal).
Glass and metal materials, which are prominently used in rigid packaging, offer high barrier packaging irrespective of shelf-life requirements. Furthermore, rigid packaging formats are vulnerable to breakage and corrosion.
Hence, brands are introducing new flexible packaging solutions, which can provide longer shelf life and convenient user experience. Plastic flexible packaging products can be made in opaque as well as transparent forms depending upon the merchandising requirements of products.
Thus, flexible packaging products are made of plastics which allow product manufacturers and brands the ability to enhance product appeal through innovative packaging designs.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
How Will Expansion of India’s Healthcare Industry Impact the Demand for Drug Delivery Solutions?
“Favorable Norms for Packaging Solution to Boost Drug Delivery Solutions Demand”
India is expected to be the largest shareholder, contributing over 41% in the South Asia drug delivery solutions market by the end of 2031. Penetration of the advance healthcare facilities and cost-effective manufacturing will create conducive environment for drug delivery solutions market in India.
According to National Health Mission, the Government of India is investing extensively to upgrade existing hospitals and develop improved healthcare infrastructure, with modern pharmaceutical packaging and facilities.
This has led to an increasing demand for safe and efficient packaging solutions for pharmaceutical products in the country. Besides this, increasing production of healthcare products by India is increasing the demand for drug delivery solutions.
As per the study, consumption of sustainable and recyclable delivery solutions has increased due to high expenditure on healthcare industry, propelling the demand in India drug delivery solutions market.
Will the Demand for Drug Delivery Solutions Increase in Japan?
“Growing Sustainability Concerns to Create Growth Opportunities for Japan Drug Delivery Solutions Market”
Future Market Insights opines, Japan is one of the key producers of drug delivery solutions in East-Asia, surpassing US$ 11.9 Bn by the end of 2031. Key players in Japan are majorly focused on developing a safe product for end users.
Also, healthcare equipment service providers from Japan are undergoing a transition towards plastic delivery solutions. As these solutions are sustainable, adoption of these solutions is increasing to reduce carbon footprint.
Subsequently, the Japan drug delivery solutions market will create an incremental opportunity of US$ 7.2 Bn between 2021 and 2031.
Category-wise Insights
Why are Bottles More Preferred as Drug Delivery Solutions?
“Bottles to Remain Highly Sought-After Packaging Format for Drug Delivery Solutions”
Bottles are widely used in healthcare sector due to the convenience in packaging. As per FMI, this segment accounted for over 40% of global market share in 2020. With increasing demand for medicines and drugs, bottles are more preferred as a safe packaging solution.
Properties such as ease in storage and handling, ease in usage is mostly affecting the use of bottles for drug delivery solutions and packaging. Due to this people are more inclined towards purchasing bottles.
As a result, the usage of bottles in drug delivery solutions will expand by 1.7x and expected to lose -490 BPS by the end of 2031.
Which is the Chief Application in Drug Delivery Solutions Market?
“Demand for Injectable Drug Delivery Solutions to Outpace the Others”
In terms of application, injectable segment will lead the application segment in global drug delivery solutions. The segment held a market share of about 36% in the year 2020, estimates FMI.
Injectable segment will continue to lead the application segment of the target market due to high demand of easy to use and disposable drug delivery solutions.
However, pulmonary and nasal segments will witness significant growth, recording incremental opportunity of US$ 16.2 Bn and US$ 12.8 Bn, respectively between 2021 and 2031.
In emerging economies, government expenditure on healthcare facilities has abruptly rose in the last decade, and the injectable segment is expected to increase by 1.9x in 2021.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Companies operating in the drug delivery solutions market are aiming at expansions and strategic partnerships with other manufacturers to expand their product manufacturing capabilities and strengthen their global footprints.
For instance,
- In November 2021, Schott AG received funding from the German Federal Ministry for the Environment (BMU) to develop climate-friendly glass production and reduce carbon emissions.
- Becton, Dickinson and Company, in November 2021, had the opening ceremony of its high-tech manufacturing facility in Zaragoza, Spain, for supporting the growth of pre-filled drug delivery systems.
- In 2021, Gerresheimer AG announced a strategic partnership with Midas Pharma for the development and marketing of its own IP autoinjector.
- In October 2021, West Pharmaceutical Services, Inc. launched a new Vialg2Bag Advanced 20 mm admixture device designed specially to maximize the benefits of point-of-care nursing.
- In August 2021, Ardagh Group S.A. announced the complete acquisition of Gores Holdings V, Inc. under a special purpose acquisition agreement with The Gores Group.
Scope Of Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2015-2020 |
|
Market Analysis |
US$ Million for Value, Mn Units for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, MEA, Oceania |
|
Key Countries Covered |
US, Canada, Brazil, Germany U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Australia, GCC Countries, and South Africa |
|
Key Segments Covered |
Product type, Material, Application and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Drug Delivery Solutions Market By Category
By Product Type:
- Bottles
- Packer Bottles
- Liquid Bottles
- Vials & Ampoules
- Blisters
- Bags & Pouches
- Prefilled Syringes & Cartridges
- Sachets
- Trays
- Tubes
- Caps & Closures
- Container, Jars & Others
By Material:
- Plastics
- PE
- LDPE
- HDPE
- PVC
- PP
- PS
- PET
- Others
- PE
- Glass
- Metal
- Paper
By Applications:
- Nasal
- Pulmonary
- Injectable
- Eye Care
- Dermal/ Transdermal
- Other Applications
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Middle East & Africa
- Oceania
Frequently Asked Questions
Adoption of advanced technology for enhancing safety and temperature monitoring is improving the demand for drug delivery solutions.
High requirement of effective & sustainable drug delivery solutions in healthcare sector will drive the demand for the drug delivery solutions market.
Top five companies operating in the drug delivery solutions market are Johnson & Johnson, Roche Holding AG, Novartis AG, Merck & Co. Inc., and GSK Plc. These companies covered nearly 22% to 23% of the overall market in 2020.
FMI has anticipated that the Europe drug delivery solutions market will exhibit growth at a CAGR of 6.1% , surpassing US$ 19.9 Bn between 2021 and 2031.
As per FMI, Japan drug delivery solutions market is expected to rise at 8.6 % CAGR, expanding by 2.3x between 2021 and 2031.
1. Executive Summary
1.1. Global Market Overview
1.2. Market Analysis
1.3. Analysis and Recommendations
1.4. Global Market Overview
1.5. Market Characteristics & Attributes
1.6. Market Statistics
1.7. Analysis and Recommendations
1.7.1. Overall Market Approach
1.7.2. Target Segment
1.7.3. Target Region
1.7.4. Differentiating Strategy
1.7.5. Expected Barriers
2. Market Overview
2.1. Market Definition
2.2. Market Taxonomy
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
5. Global Drug Delivery Solutions Market Demand Analysis 2015-2020 and Forecast, 2021-2031
5.1. Historical Market Volume (Bn Units) Analysis, 2015-2020
5.2. Current and Future Market Volume (Bn Units) Projections, 2021-2031
5.3. Y-o-Y Growth Trend Analysis
6. Global Drug Delivery Solutions Market - Pricing Analysis
6.1. Regional Pricing Analysis, by Product
6.2. Pricing Break-up
6.3. Global Average Pricing Analysis Benchmark
7. Global Drug Delivery Solutions Market Demand (US$ Mn) Analysis 2015-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Global Packaging Market Overview
8.2. Global Plastic Packaging Market Overview
8.3. Global Flexible Packaging Market Overview
8.4. Global Rigid Packaging Market Outlook
8.5. Global Pharmaceutical Industry Outlook
8.6. Macro-Economic Factors & Co-relation Analysis
8.6.1. Global GDP
8.6.2. GDP Per Capita
8.6.3. Manufacturing Value Added
8.6.4. Rigid Packaging Industry
8.6.5. Packaging Industry
8.7. Forecast Factors - Relevance & Impact
8.7.1. GDP Growth
8.7.2. Segmental Revenue Growth of Key Players
8.7.3. Manufacturing Value Added Growth
8.7.4. Rigid Packaging Industry Growth
8.7.5. Packaging Industry Growth
8.8. Value Chain Analysis
8.8.1. Key Market Participants
8.8.1.1. Raw Material Suppliers
8.8.1.2. Drug Delivery Solutions/Format Manufacturers
8.8.1.3. End-users
8.8.2. Profitability Margin
8.9. Market Dynamics
8.9.1. Drivers
8.9.2. Restraints
8.9.3. Opportunity Analysis
9. Impact of COVID-19
9.1. Current Statistics and Probable Future Impact
9.2. Impact of COVID-19 on Drug Delivery Solutions Market
10. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Product
10.1. Introduction
10.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Product, 2015-2020
10.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Product, 2021-2031
10.3.1. Bottles
10.3.1.1. Packer Bottles
10.3.1.2. Liquid Bottles
10.3.2. Vials & Ampoules
10.3.3. Blisters
10.3.4. Bags & Pouches
10.3.5. Prefilled Syringes & Cartridges
10.3.6. Sachets
10.3.7. Trays
10.3.8. Tubes
10.3.9. Caps & Closures
10.3.10. Container, Jars & Others
10.4. Market Attractiveness Analysis, by Product
11. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, By Material
11.1. Introduction
11.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Material, 2015-2020
11.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Material, 2021-2031
11.3.1. Plastics
11.3.1.1. PE
11.3.1.1.1. LDPE
11.3.1.1.2. HDPE
11.3.1.2. PVC
11.3.1.3. PP
11.3.1.4. PS
11.3.1.5. PET
11.3.1.6. Others
11.3.2. Glass
11.3.3. Metals
11.3.4. Paper
11.4. Market Attractiveness Analysis, by Material
12. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Application
12.1. Introduction
12.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Application, 2015-2020
12.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Application, 2021-2031
12.3.1. Nasal
12.3.2. Pulmonary
12.3.3. Injectable
12.3.4. Eye Care
12.3.5. Dermal/Transdermal
12.3.6. Other Applications
12.4. Market Attractiveness Analysis, by Application
13. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Region, 2015-2020
13.3. Current Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Region, 2021-2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Middle East and Africa (MEA)
13.3.7. Oceania
13.4. Market Attractiveness Analysis, by Region
14. North America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
14.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Material
14.3.4. By Applications
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Material
14.4.4. By Applications
14.5. Key Market Participants - Intensity Mapping
15. Latin America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
15.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Material
15.3.4. By Applications
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Material
15.4.4. By Applications
15.5. Key Market Participants - Intensity Mapping
16. Europe Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
16.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Nordics
16.3.1.8. Russia
16.3.1.9. Poland
16.3.1.10. Rest of Europe
16.3.2. By Product
16.3.3. By Material
16.3.4. By Applications
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Material
16.4.4. By Applications
16.5. Key Market Participants - Intensity Mapping
17. South Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
17.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Material
17.3.4. By Applications
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Material
17.4.4. By Applications
17.5. Key Market Participants - Intensity Mapping
18. East Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
18.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. Rest of East Asia
18.3.2. By Product
18.3.3. By Material
18.3.4. By Applications
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Material
18.4.4. By Applications
18.5. Key Market Participants - Intensity Mapping
18.6.
19. Oceania Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
19.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Material
19.3.4. By Applications
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Material
19.4.4. By Applications
19.5. Key Market Participants - Intensity Mapping
20. Middle East and Africa Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020
20.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Material
20.3.4. By Applications
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Material
20.4.4. By Applications
20.5. Key Market Participants - Intensity Mapping
21. Drug Delivery Solutions Market Country-wise Analysis and Forecast
21.1. U.S. Drug Delivery Solutions Market Analysis 2021 & 2031
21.1.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.1.1.1. By Product
21.1.1.2. By Material
21.1.1.3. By Applications
21.2. Canada Drug Delivery Solutions Market Analysis 2021 & 2031
21.2.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.2.1.1. By Product
21.2.1.2. By Material
21.2.1.3. By Applications
21.3. Brazil Drug Delivery Solutions Market Analysis 2021 & 2031
21.3.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.3.1.1. By Product
21.3.1.2. By Material
21.3.1.3. By Applications
21.4. Mexico Drug Delivery Solutions Market Analysis 2021 & 2031
21.4.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.4.1.1. By Product
21.4.1.2. By Material
21.4.1.3. By Applications
21.5. Germany Drug Delivery Solutions Market Analysis 2021 & 2031
21.5.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.5.1.1. By Product
21.5.1.2. By Material
21.5.1.3. By Applications
21.6. Italy Drug Delivery Solutions Market Analysis 2021 & 2031
21.6.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.6.1.1. By Product
21.6.1.2. By Material
21.6.1.3. By Applications
21.7. France Drug Delivery Solutions Market Analysis 2021 & 2031
21.7.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.7.1.1. By Product
21.7.1.2. By Material
21.7.1.3. By Applications
21.8. U.K. Drug Delivery Solutions Market Analysis 2021 & 2031
21.8.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.8.1.1. By Product
21.8.1.2. By Material
21.8.1.3. By Applications
21.9. Spain Drug Delivery Solutions Market Analysis 2021 & 2031
21.9.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.9.1.1. By Product
21.9.1.2. By Material
21.9.1.3. By Applications
21.10. Russia Drug Delivery Solutions Market Analysis 2021 & 2031
21.10.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.10.1.1. By Product
21.10.1.2. By Material
21.10.1.3. By Applications
21.11. GCC Countries Drug Delivery Solutions Market Analysis 2021 & 2031
21.11.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.11.1.1. By Product
21.11.1.2. By Material
21.11.1.3. By Applications
21.12. China Drug Delivery Solutions Market Analysis 2021 & 2031
21.12.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.12.1.1. By Product
21.12.1.2. By Material
21.12.1.3. By Applications
21.13. Japan Drug Delivery Solutions Market Analysis 2021 & 2031
21.13.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.13.1.1. By Product
21.13.1.2. By Material
21.14. India Drug Delivery Solutions Market Analysis 2021 & 2031
21.14.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.14.1.1. By Product
21.14.1.2. By Material
21.15. Australia Drug Delivery Solutions Market Analysis 2021 & 2031
21.15.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy
21.15.1.1. By Product
21.15.1.2. By Material
21.15.1.3. By Applications
22. Market Structure Analysis
22.1. Market Analysis, by Tier of Drug Delivery Solutions Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Customer Deep Dive
23.3.1. Drug Manufacturers
(Key Customers)
23.3.1.1. Pfizer Inc.
23.3.1.2. GlaxoSmithKline (GSK) plc.
23.3.1.3. Sanofi
23.3.1.4. Roche Holding AG
23.3.1.5. Novartis AG
23.3.1.6. Allergan (Abbvie Inc.)
23.3.1.7. Johnson & Johnson
23.3.1.8. Merck & Co., Inc.
23.3.1.9. Sun Pharmaceutical Industries Ltd.
23.3.1.10. Cadila Healthcare
23.3.2. Drug Delivery Solutions Manufacturers
(Key Global Market Players)
23.3.3. Amcor Plc
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Schott AG
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. Gerresheimer AG
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Berry Global, Inc.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. Klockner Pentaplast Group
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Becton, Dickinson and Company
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Ardagh Group S.A.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. West Pharmaceutical Service, Inc.
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Bilcare Limited
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. Wipak Group
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Mondi Plc
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. Sealed Air Corporation
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
23.3.15. Constantia Flexibles
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Profitability by Market Segments
23.3.15.4. Sales Footprint
23.3.15.5. Strategy Overview
23.3.15.5.1. Marketing Strategy
23.3.15.5.2. Product Strategy
23.3.15.5.3. Channel Strategy
23.3.16. Clondalkin Group Holdings B.V.
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Profitability by Market Segments
23.3.16.4. Sales Footprint
23.3.16.5. Strategy Overview
23.3.16.5.1. Marketing Strategy
23.3.16.5.2. Product Strategy
23.3.16.5.3. Channel Strategy
23.3.17. West Rock Company
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Profitability by Market Segments
23.3.17.4. Sales Footprint
23.3.17.5. Strategy Overview
23.3.17.5.1. Marketing Strategy
23.3.17.5.2. Product Strategy
23.3.17.5.3. Channel Strategy
23.3.18. UDG Healthcare plc
23.3.18.1. Overview
23.3.18.2. Product Portfolio
23.3.18.3. Profitability by Market Segments
23.3.18.4. Sales Footprint
23.3.18.5. Strategy Overview
23.3.18.5.1. Marketing Strategy
23.3.18.5.2. Product Strategy
23.3.18.5.3. Channel Strategy
23.3.19. Catalent, Inc.
23.3.19.1. Overview
23.3.19.2. Product Portfolio
23.3.19.3. Profitability by Market Segments
23.3.19.4. Sales Footprint
23.3.19.5. Strategy Overview
23.3.19.5.1. Marketing Strategy
23.3.19.5.2. Product Strategy
23.3.19.5.3. Channel Strategy
23.3.20. Sonocco Products Company
23.3.20.1. Overview
23.3.20.2. Product Portfolio
23.3.20.3. Profitability by Market Segments
23.3.20.4. Sales Footprint
23.3.20.5. Strategy Overview
23.3.20.5.1. Marketing Strategy
23.3.20.5.2. Product Strategy
23.3.20.5.3. Channel Strategy
23.3.21. Reike Corporation
23.3.21.1. Overview
23.3.21.2. Product Portfolio
23.3.21.3. Profitability by Market Segments
23.3.21.4. Sales Footprint
23.3.21.5. Strategy Overview
23.3.21.5.1. Marketing Strategy
23.3.21.5.2. Product Strategy
23.3.21.5.3. Channel Strategy
23.3.22. Adelphi Healthcare Packaging
23.3.22.1. Overview
23.3.22.2. Product Portfolio
23.3.22.3. Profitability by Market Segments
23.3.22.4. Sales Footprint
23.3.22.5. Strategy Overview
23.3.22.5.1. Marketing Strategy
23.3.22.5.2. Product Strategy
23.3.22.5.3. Channel Strategy
(Asia Pacific based Key Market Players)
23.3.23. Nipro Corporation
23.3.23.1. Overview
23.3.23.2. Product Portfolio
23.3.23.3. Profitability by Market Segments
23.3.23.4. Sales Footprint
23.3.23.5. Strategy Overview
23.3.23.5.1. Marketing Strategy
23.3.23.5.2. Product Strategy
23.3.23.5.3. Channel Strategy
23.3.24. Uflex Ltd.
23.3.24.1. Overview
23.3.24.2. Product Portfolio
23.3.24.3. Profitability by Market Segments
23.3.24.4. Sales Footprint
23.3.24.5. Strategy Overview
23.3.24.5.1. Marketing Strategy
23.3.24.5.2. Product Strategy
23.3.24.5.3. Channel Strategy
23.3.25. ACG Pharmapack Pvt. Ltd.
23.3.25.1. Overview
23.3.25.2. Product Portfolio
23.3.25.3. Profitability by Market Segments
23.3.25.4. Sales Footprint
23.3.25.5. Strategy Overview
23.3.25.5.1. Marketing Strategy
23.3.25.5.2. Product Strategy
23.3.25.5.3. Channel Strategy
23.3.26. Piramal Glass Limited
23.3.26.1. Overview
23.3.26.2. Product Portfolio
23.3.26.3. Profitability by Market Segments
23.3.26.4. Sales Footprint
23.3.26.5. Strategy Overview
23.3.26.5.1. Marketing Strategy
23.3.26.5.2. Product Strategy
23.3.26.5.3. Channel Strategy
23.3.27. Parekhplast India Ltd.
23.3.27.1. Overview
23.3.27.2. Product Portfolio
23.3.27.3. Profitability by Market Segments
23.3.27.4. Sales Footprint
23.3.27.5. Strategy Overview
23.3.27.5.1. Marketing Strategy
23.3.27.5.2. Product Strategy
23.3.27.5.3. Channel Strategy
23.3.28. Shandong Pharmaceutical Glass Co., Ltd.
23.3.28.1. Overview
23.3.28.2. Product Portfolio
23.3.28.3. Profitability by Market Segments
23.3.28.4. Sales Footprint
23.3.28.5. Strategy Overview
23.3.28.5.1. Marketing Strategy
23.3.28.5.2. Product Strategy
23.3.28.5.3. Channel Strategy
23.3.29. Avesta Continental Pack
23.3.29.1. Overview
23.3.29.2. Product Portfolio
23.3.29.3. Profitability by Market Segments
23.3.29.4. Sales Footprint
23.3.29.5. Strategy Overview
23.3.29.5.1. Marketing Strategy
23.3.29.5.2. Product Strategy
23.3.29.5.3. Channel Strategy
23.3.30. Shanghai Tongpeng Electric Material Co., Ltd.
23.3.30.1. Overview
23.3.30.2. Product Portfolio
23.3.30.3. Profitability by Market Segments
23.3.30.4. Sales Footprint
23.3.30.5. Strategy Overview
23.3.30.5.1. Marketing Strategy
23.3.30.5.2. Product Strategy
23.3.30.5.3. Channel Strategy
23.3.31. Khemka Glass
23.3.31.1. Overview
23.3.31.2. Product Portfolio
23.3.31.3. Profitability by Market Segments
23.3.31.4. Sales Footprint
23.3.31.5. Strategy Overview
23.3.31.5.1. Marketing Strategy
23.3.31.5.2. Product Strategy
23.3.31.5.3. Channel Strategy
23.3.32. TPAC Packaging India Private Limited (Sunpet)
23.3.32.1. Overview
23.3.32.2. Product Portfolio
23.3.32.3. Profitability by Market Segments
23.3.32.4. Sales Footprint
23.3.32.5. Strategy Overview
23.3.32.5.1. Marketing Strategy
23.3.32.5.2. Product Strategy
23.3.32.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Product, 2015H-2031F
Table 02: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Product, 2015H-2031F
Table 03: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Material, 2015H-2031F
Table 04: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Material, 2015H-2031F
Table 05: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Applications, 2015H-2031F
Table 06: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Applications, 2015H-2031F
Table 07: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Region, 2015H-2031F
Table 08: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Region, 2015H-2031F
Table 09: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 10: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 11: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 12: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 13: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 14: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 15: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 16: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 17: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 18: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 19: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 20: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 21: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 22: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 23: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 24: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 25: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 26: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 27: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 28: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 29: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 30: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 31: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 32: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 33: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 34: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 35: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 36: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 37: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 38: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 39: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 40: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 41: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 42: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 43: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 44: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 45: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 46: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 47: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 48: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 49: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 50: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 51: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 52: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 53: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 54: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 55: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 56: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Table 57: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F
Table 58: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F
Table 59: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F
Table 60: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F
Table 61: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F
Table 62: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F
Table 63: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F
Table 64: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Drug Delivery Solutions Market Share Analysis, By Product, 2021E & 2031F
Figure 02: Global Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 03: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Product, 2019H-2031F
Figure 04: Global Drug Delivery Solutions Market Share Analysis, By Material, 2021E & 2031F
Figure 05: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 06: Global Drug Delivery Solutions Market Attractiveness Analysis, By Material, 2021E-2031F
Figure 07: Global Drug Delivery Solutions Market Share Analysis, By Applications, 2021E & 2031F
Figure 08: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Applications, 2019H-2031F
Figure 09: Global Drug Delivery Solutions Market Attractiveness Analysis, By Applications, 2021E-2031F
Figure 10: Global Drug Delivery Solutions Market Share Analysis, By Region 2021E & 2031F
Figure 11: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Region, 2019H-2031F
Figure 12: Global Drug Delivery Solutions Market Attractiveness Analysis, By Region, 2021E-2031F
Figure 13: North America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 14: North America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 15: North America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 16: North America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 17: Latin America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 18: Latin America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 19: Latin America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 20: Latin America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 21: Europe Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 22: Europe Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 23: Europe Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 24: Europe Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 25: South Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 26: South Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 27: South Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 28: South Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 29: East Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 30: East Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 31: East Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 32: East Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 33: Oceania Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 34: Oceania Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 35: Oceania Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 36: Oceania Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 37: Middle East and Africa Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F
Figure 38: Middle East and Africa Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F
Figure 39: Middle East and Africa Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)
Figure 40: Middle East and Africa Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F
Figure 41: U.S. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 42: U.S. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 43: U.S. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 44: Canada Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 45: Canada Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 46: Canada Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 47: Brazil Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 48: Brazil Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 49: Brazil Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 50: Mexico Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 51: Mexico Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 52: Mexico Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 53: Germany Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 54: Germany Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 55: Germany Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 56: Italy Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 57: Italy Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 58: Italy Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 59: France Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 60: France Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 61: France Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 62: U.K. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 63: U.K. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 64: U.K. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 65: Spain Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 66: Spain Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 67: Spain Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 68: Russia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 69: Russia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 70: Russia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 71: GCC Countries Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 72: GCC Countries Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 73: GCC Countries Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 74: China Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 75: China Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 76: China Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 77: Japan Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 78: Japan Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 79: Japan Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 80: India Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 81: India Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 82: India Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Figure 83: Australia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)
Figure 84: Australia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)
Figure 85: Australia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Need specific information?
Request CustomizationExplore Packaging Insights
View Reports
